following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv)..
it shows that the longest waits for cancer treatment have soared since 2010..
plemmons and co-authors disclosed no relevant relationships with industry..